Pfizer–BioNTech COVID-19 vaccine: Interim recommendations and more information
|
This interim guidance has been developed based on the advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) at its 5 January 2021 extraordinary meeting for the Pfizer/BioNTech mRNA COVID-19 vaccine. Additional information: |